XML 21 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
 5 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2022
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:            
Net income (loss) $ 0       $ (31,545,000) $ (10,019,000)
Adjustments to reconcile net loss to cash used in by operating activities:            
Depreciation and amortization         1,534,000 1,886,000
Stock-based compensation         1,739,000 2,989,000
Amortization of operating right of use assets         1,068,000 840,000
Provision for excess and obsolete inventory         269,000 246,000
Non-cash interest expense on government assistance         1,722,000 137,000
Unrealized foreign exchange loss (gain)         (100,000) (287,000)
Non-cash interest expense on convertible debt           5,095,000
Gain on settlement of warrant liability         0 (7,836,000)
Gain on investments in marketable securities         (1,163,000) 0
Gain on debt extinguishment         0 (3,873,000)
Interest benefit on debt         (19,000)  
Government assistance         (7,140,000) (12,027,000)
Fair value of warrants issued for services           451,000
Non-cash lease expense           201,000
Change in operating assets and liabilities:            
Trade accounts receivable         163,000 8,002,000
Research incentives receivable         2,236,000 (9,053,000)
Inventories         182,000 (652,000)
Prepaid expenses and other current assets         (1,012,000) (16,000)
Trade accounts payable         (379,000) 1,279,000
Accrued expenses and other current liabilities         578,000 (5,579,000)
Deferred revenue         (1,902,000) (335,000)
Operating lease liabilities         (1,031,000) (736,000)
Net cash used in operating activities         (34,800,000) (29,287,000)
Cash flows from investing activities:            
Purchase of property and equipment         (1,774,000) (736,000)
Purchase of software         (225,000) (53,000)
Net cash used in investing activities         (1,999,000) (789,000)
Cash flows from financing activities:            
Proceeds from issuance of preferred stock for cash         43,600,000 43,679,000
Proceeds from government assistance         25,147,000  
Proceeds from debt financing         111,000  
Share issuance costs           (542,000)
Proceeds from issuance of common stock upon exercise of stock options         85,000 5,000
Proceeds from issuance of common stock 1          
Debt payments 0       (31,000)  
Net cash provided by financing activities 1       24,913,000 43,144,000
Government Loan Payment         (399,000)  
Proceeds from exercise of warrants           2,000
Effect of exchange rate changes on cash and cash equivalents 0       34,000 (13,000)
Net (decrease) increase in cash and cash equivalents 1       (11,852,000) 13,055,000
Cash and cash equivalents at beginning of period $ 9,483,000 $ 21,335,000   21,335,000 8,280,000
Cash and cash equivalents at end of period 1 1   $ 21,335,000 9,483,000 21,335,000
Supplemental disclosure of noncash investing and financial activities:            
Operating lease right-of-use assets recognized in exchange for new operating lease obligations         11,870,000 4,932,000
Acquisition of property and equipment included in accounts payable         14,000 (79,000)
Cash payments included in the measurement of operating lease liabilities         1,573,000 1,474,000
Unpaid deferred costs         1,142,000  
DWave System [Member]            
Cash flows from operating activities:            
Net income (loss)   (24,815,000) (13,496,000)      
Adjustments to reconcile net loss to cash used in by operating activities:            
Depreciation and amortization   705,000 747,000      
Stock-based compensation   1,600,000 330,000      
Amortization of operating right of use assets   459,000 497,000      
Provision for excess and obsolete inventory   265,000 219,000      
Non-cash interest expense on government assistance   1,955,000 385,000      
Non-cash final fee payment for Venture Loan   583,000 0      
Unrealized foreign exchange loss (gain)   (349,000) 44,000      
Change in operating assets and liabilities:            
Trade accounts receivable   (505,000) (126,000)      
Research incentives receivable   (851,000) (5,339,000)      
Inventories   (301,000) 39,000      
Prepaid expenses and other current assets   (4,449,000) (288,000)      
Trade accounts payable   107,000 (1,764,000)      
Accrued expenses and other current liabilities   4,578,000 (733,000)      
Deferred revenue   (54,000) (324,000)      
Operating lease liabilities   (427,000) (459,000)      
Net cash used in operating activities   (21,499,000) (20,268,000)      
Cash flows from investing activities:            
Purchase of property and equipment   (175,000) (1,069,000)      
Purchase of software   (43,000) (196,000)      
Net cash used in investing activities   (218,000) (1,265,000)      
Cash flows from financing activities:            
Proceeds from government assistance   3,178,000 13,458,000      
Proceeds from debt financing   19,870,000 0      
Proceeds from issuance of common stock upon exercise of stock options   141,000 67,000      
Debt payments   (424,000) (398,000)      
Net cash provided by financing activities   22,765,000 13,127,000      
Effect of exchange rate changes on cash and cash equivalents   (65,000) 262,000      
Net (decrease) increase in cash and cash equivalents   983,000 (8,144,000)      
Cash and cash equivalents at beginning of period   9,483,000 21,335,000   21,335,000  
Cash and cash equivalents at end of period 10,466,000 10,466,000 13,191,000 21,335,000 9,483,000 21,335,000
Supplemental disclosure of noncash investing and financial activities:            
Acquisition of property and equipment included in accounts payable   3,000 21,000      
Unpaid deferred costs   3,734,000 0      
DPCM Capital, Inc. [Member]            
Cash flows from operating activities:            
Net income (loss)   2,170,190 14,064,062 (27,406,287) 24,245,377  
Adjustments to reconcile net loss to cash used in by operating activities:            
Interest earned on marketable securities held in Trust Account   (427,040) (71,548) $ (48,914) $ (115,883)  
Transaction cost allocatable to warrants       381556.00% 0.00%  
Change in fair value of warrant liabilities   (4,487,400) (15,480,000) $ 26,740,000 $ (27,912,600)  
Unrealized (gain) loss on marketable securities held in Trust Account   (16,538) 6,283 (9,563) (8,962)  
Reduction of deferred underwriting fee   (234,500) 0      
Change in operating assets and liabilities:            
Prepaid expenses   105,734 48,970 (389,413) 213,190  
Income taxes payable   19,801 0      
Accounts payable and accrued expenses   2,402,437 701,110 270,054 2,619,041  
Net cash used in operating activities   (467,316,000) (731,123,000) (462,567) (959,837)  
Cash flows from investing activities:            
Investment of cash into Trust Account       (300,000,000)    
Net cash used in investing activities       (300,000,000)    
Cash flows from financing activities:            
Share issuance costs       (477,876)    
Proceeds from promissory note—related party   420,000 0 (250,000)    
Proceeds from issuance of common stock       25,000    
Proceeds from sale of Units, net of underwriting discounts paid       294,000,000    
Proceeds from sale of Private Placements Warrants       8,000,000    
Repayment of promissory note—related party       250,000    
Net cash provided by financing activities   420,000 0 301,547,124    
Net (decrease) increase in cash and cash equivalents   (47,316,000) (731,123,000) 1,084,557,000 (959,837,000)  
Cash and cash equivalents at beginning of period   124,720 1,084,557 0 1,084,557  
Cash and cash equivalents at end of period $ 77,404 77,404 353,434 1,084,557 124,720 $ 1,084,557
Supplemental disclosure of noncash investing and financial activities:            
Reduction of deferred underwriting fee   $ (10,265,500) $ 0      
Accretion for Class A common stock subject to possible redemption       23,196,320    
Deferred underwriting fee payable       10,500,000    
Supplementary cash flow information:            
Cash paid for income taxes       $ 0 $ 10,424